Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
36
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bourdon David | Chief Financial Officer | 12 | $0 | $0 | 2022-01-04 |
| Chen Christopher J | Director | 3 | $0 | $0 | 2022-01-04 |
| Abbott Swati Bargotra | Director | 5 | $0 | $0 | 2022-01-04 |
| Kamal Mostafa | CEO, Magellan Rx Management | 115 | $0 | $9.48M | 2022-01-04 |
| Norwalk Leslie V | Director | 5 | $0 | $0 | 2022-01-04 |
| Haddock David | General Counsel & Secretary | 10 | $0 | $0 | 2022-01-04 |
| Lewis Clapper Caskie | Chief Human Resources Officer | 133 | $0 | $17.98M | 2022-01-04 |
| Feld Peter A | Director | 11 | $0 | $0 | 2022-01-04 |
| MACKENZIE GREGORY SCOTT | Director | 7 | $0 | $0 | 2022-01-04 |
| SANSONE GUY P | Director | 5 | $0 | $0 | 2022-01-04 |
| SHULMAN STEVEN J | Director | 6 | $0 | $0 | 2022-01-04 |
| WEST JEFFREY N | SVP & Controller | 267 | $49.1K | $18.01M | 2022-01-04 |
| JOSEPHSON MURAL R | Director | 3 | $0 | $0 | 2022-01-04 |
| FASOLA KENNETH J | Chief Executive Officer | 20 | $0 | $0 | 2022-01-04 |
| MURRAY JAMES E | President and COO | 23 | $304.3K | $0 | 2022-01-04 |
| Rubin Jonathan N | Chief Financial Officer | 220 | $0 | $28.35M | 2020-03-04 |
| MCBRIDE WILLIAM J | Director | 10 | $0 | $0 | 2019-06-21 |
| FINE PERRY G MD | Director | 6 | $0 | $0 | 2019-06-21 |
| DIAMENT MICHAEL | Director | 11 | $0 | $0 | 2019-06-21 |
| SMITH BARRY M | Director | 55 | $585.6K | $9.01M | 2019-03-05 |
| GREGOIRE DANIEL N | General Counsel and Secretary | 147 | $0 | $23.28M | 2019-03-05 |
| Simas Matthew Joseph | Director | 1 | $0 | $0 | 2018-05-24 |
| Agwunobi John O | Director | 5 | $0 | $0 | 2018-05-24 |
| BROSHY ERAN | Director | 9 | $0 | $571.8K | 2018-05-24 |
| Srivastava Sanjeev K | CEO, Magellan Plan Services | 23 | $0 | $0 | 2018-03-07 |
| James Kay Coles | Director | 5 | $0 | $0 | 2017-05-24 |
| SAMMONS MARY F | Director | 6 | $0 | $0 | 2017-05-24 |
| LEBLANC ROBERT M | Director | 5 | $556.0K | $0 | 2015-05-20 |
| RESSNER MICHAEL P | Director | 4 | $0 | $0 | 2015-05-20 |
| Blasi Tina | CEO, National Imaging Assoc. | 114 | $0 | $6.02M | 2015-03-30 |
| Field Robert W | CEO, Magellan Rx Management | 8 | $0 | $0 | 2015-03-05 |
| LERER RENE | Director | 122 | $0 | $25.69M | 2013-12-06 |
| FORREST WILLIAM D | Director | 2 | $0 | $0 | 2013-05-22 |
| Mageau Kim Marie | President, Magellan Pharm Sols | 2 | $0 | $0 | 2012-03-05 |
| Dixon Keith | President, Behavioral Health | 2 | $0 | $0 | 2012-03-05 |
| Rohan Karen | President | 8 | $0 | $0 | 2012-03-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bourdon David | Chief Financial Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 4,362 | — | $0 | 0 | SEC↗ |
| Bourdon David | Chief Financial Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 16,963 | — | $0 | 0 | SEC↗ |
| Bourdon David | Chief Financial Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 4,383 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 8,580 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 22,196 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 43,080 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 18,411 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer deriv | 2022-01-04 | 2022-01-04 | 27,743 | — | $0 | 0 | SEC↗ |
| Haddock David | General Counsel & Secretary | D To issuer deriv | 2022-01-04 | 2022-01-04 | 8,473 | — | $0 | 0 | SEC↗ |
| Haddock David | General Counsel & Secretary | D To issuer deriv | 2022-01-04 | 2022-01-04 | 10,605 | — | $0 | 0 | SEC↗ |
| Haddock David | General Counsel & Secretary | D To issuer deriv | 2022-01-04 | 2022-01-04 | 11,309 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 24,748 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 10,679 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 15,602 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 25,439 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 12,482 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer deriv | 2022-01-04 | 2022-01-04 | 27,205 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 4,868 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 20,281 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 14,057 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 12,949 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 6,085 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 5,307 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 9,733 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 30,843 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer deriv | 2022-01-04 | 2022-01-04 | 12,330 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 28,271 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 25,346 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 3,262 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 18,206 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 14,006 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer deriv | 2022-01-04 | 2022-01-04 | 14,566 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 2,365 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 3,404 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 4,808 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 3,538 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 1,474 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 928 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer deriv | 2022-01-04 | 2022-01-04 | 1,447 | — | $0 | 0 | SEC↗ |
| Abbott Swati Bargotra | Director | D To issuer | 2022-01-04 | 2022-01-04 | 6,847 | — | $0 | 0 | SEC↗ |
| Bourdon David | Chief Financial Officer | D To issuer | 2022-01-04 | 2022-01-04 | 1,330 | — | $0 | 0 | SEC↗ |
| Chen Christopher J | Director | D To issuer | 2022-01-04 | 2022-01-04 | 2,911 | — | $0 | 0 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | D To issuer | 2022-01-04 | 2022-01-04 | 17,141 | — | $0 | 0 | SEC↗ |
| Haddock David | General Counsel & Secretary | D To issuer | 2022-01-04 | 2022-01-04 | 2,961 | — | $0 | 0 | SEC↗ |
| JOSEPHSON MURAL R | Director | D To issuer | 2022-01-04 | 2022-01-04 | 2,911 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | D To issuer | 2022-01-04 | 2022-01-04 | 5,994 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | D To issuer | 2022-01-04 | 2022-01-04 | 19,510 | — | $0 | 0 | SEC↗ |
| MACKENZIE GREGORY SCOTT | Director | D To issuer | 2022-01-04 | 2022-01-04 | 10,594 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | D To issuer | 2022-01-04 | 2022-01-04 | 13,203 | — | $0 | 0 | SEC↗ |
| Norwalk Leslie V | Director | D To issuer | 2022-01-04 | 2022-01-04 | 5,698 | — | $0 | 0 | SEC↗ |
| SANSONE GUY P | Director | D To issuer | 2022-01-04 | 2022-01-04 | 7,973 | — | $0 | 0 | SEC↗ |
| SHULMAN STEVEN J | Director | D To issuer | 2022-01-04 | 2022-01-04 | 27,451 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | D To issuer | 2022-01-04 | 2022-01-04 | 25,692 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 228,603 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 1,419,053 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 5,698 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 305,614 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 200,300 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 85,229 | — | $0 | 0 | SEC↗ |
| Feld Peter A | Director | D To issuer | 2022-01-04 | 2022-01-04 | 130,301 | — | $0 | 0 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise deriv | 2022-01-02 | 2022-01-04 | 3,262 | — | $0 | 3,262 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise | 2022-01-02 | 2022-01-04 | 3,262 | — | $0 | 14,074 | SEC↗ |
| MURRAY JAMES E | President and COO | F Tax w/h | 2022-01-02 | 2022-01-04 | 871 | $94.99 | $82.7K | 13,203 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise deriv | 2021-12-02 | 2021-12-06 | 8,580 | — | $0 | 8,580 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise | 2021-12-02 | 2021-12-06 | 8,580 | — | $0 | 20,517 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | F Tax w/h | 2021-12-02 | 2021-12-06 | 3,376 | $94.62 | $319.4K | 17,141 | SEC↗ |
| Bourdon David | Chief Financial Officer | M Exercise deriv | 2021-10-01 | 2021-10-05 | 2,192 | — | $0 | 4,383 | SEC↗ |
| Bourdon David | Chief Financial Officer | F Tax w/h | 2021-10-01 | 2021-10-05 | 862 | $94.68 | $81.6K | 1,330 | SEC↗ |
| Bourdon David | Chief Financial Officer | M Exercise | 2021-10-01 | 2021-10-05 | 2,192 | — | $0 | 2,192 | SEC↗ |
| Abbott Swati Bargotra | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 6,847 | SEC↗ |
| Chen Christopher J | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 2,911 | SEC↗ |
| JOSEPHSON MURAL R | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 2,911 | SEC↗ |
| MACKENZIE GREGORY SCOTT | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 10,594 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 5,698 | SEC↗ |
| SANSONE GUY P | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 7,973 | SEC↗ |
| SHULMAN STEVEN J | Director | A Award | 2021-08-13 | 2021-08-13 | 789 | — | $0 | 27,451 | SEC↗ |
| Feld Peter A | Director | A Award | 2021-08-13 | 2021-08-17 | 789 | — | $0 | 5,698 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2021-03-05 | 2021-03-08 | 1,447 | — | $0 | 1,447 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2021-03-05 | 2021-03-08 | 839 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2021-03-05 | 2021-03-08 | 839 | — | $0 | 24,922 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2021-03-05 | 2021-03-08 | 677 | $93.29 | $63.2K | 25,692 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2021-03-05 | 2021-03-08 | 1,447 | — | $0 | 26,369 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise deriv | 2021-03-04 | 2021-03-05 | 11,099 | — | $0 | 22,196 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise deriv | 2021-03-04 | 2021-03-05 | 2,435 | — | $0 | 4,868 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise deriv | 2021-03-04 | 2021-03-05 | 7,284 | — | $0 | 14,566 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2021-03-04 | 2021-03-05 | 1,769 | — | $0 | 3,538 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise deriv | 2021-03-04 | 2021-03-05 | 6,242 | — | $0 | 12,482 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | F Tax w/h | 2021-03-04 | 2021-03-05 | 4,366 | $93.47 | $408.1K | 11,937 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise | 2021-03-04 | 2021-03-05 | 11,099 | — | $0 | 16,303 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | F Tax w/h | 2021-03-04 | 2021-03-05 | 1,109 | $93.47 | $103.7K | 24,195 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise | 2021-03-04 | 2021-03-05 | 2,435 | — | $0 | 25,304 | SEC↗ |
| MURRAY JAMES E | President and COO | F Tax w/h | 2021-03-04 | 2021-03-05 | 2,866 | $93.47 | $267.9K | 10,812 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise | 2021-03-04 | 2021-03-05 | 7,284 | — | $0 | 13,678 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2021-03-04 | 2021-03-05 | 1,769 | — | $0 | 24,645 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2021-03-04 | 2021-03-05 | 562 | $93.47 | $52.5K | 24,083 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise | 2021-03-04 | 2021-03-05 | 6,242 | — | $0 | 9,066 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | F Tax w/h | 2021-03-04 | 2021-03-05 | 3,072 | $93.47 | $287.1K | 5,994 | SEC↗ |
| Haddock David | General Counsel & Secretary | A Award deriv | 2021-03-03 | 2021-03-04 | 11,309 | — | $0 | 11,309 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | A Award deriv | 2021-03-03 | 2021-03-05 | 43,080 | — | $0 | 43,080 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | A Award deriv | 2021-03-03 | 2021-03-05 | 9,733 | — | $0 | 9,733 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2021-03-03 | 2021-03-05 | 28,271 | — | $0 | 28,271 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2021-03-03 | 2021-03-05 | 4,808 | — | $0 | 4,808 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | A Award deriv | 2021-03-03 | 2021-03-05 | 25,439 | — | $0 | 25,439 | SEC↗ |
| Bourdon David | Chief Financial Officer | A Award deriv | 2021-03-03 | 2021-03-05 | 16,963 | — | $0 | 16,963 | SEC↗ |
| Haddock David | General Counsel & Secretary | M Exercise deriv | 2021-03-02 | 2021-03-04 | 4,237 | — | $0 | 8,473 | SEC↗ |
| Haddock David | General Counsel & Secretary | F Tax w/h | 2021-03-02 | 2021-03-04 | 1,276 | $93.00 | $118.7K | 2,961 | SEC↗ |
| Haddock David | General Counsel & Secretary | M Exercise | 2021-03-02 | 2021-03-04 | 4,237 | — | $0 | 4,237 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise deriv | 2021-01-02 | 2021-01-05 | 3,262 | — | $0 | 6,524 | SEC↗ |
| MURRAY JAMES E | President and COO | M Exercise | 2021-01-02 | 2021-01-05 | 3,262 | — | $0 | 7,762 | SEC↗ |
| MURRAY JAMES E | President and COO | F Tax w/h | 2021-01-02 | 2021-01-05 | 1,368 | $82.84 | $113.3K | 6,394 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-12-09 | 2020-12-11 | 2,793 | $79.69 | $222.6K | 2,824 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise deriv | 2020-12-02 | 2020-12-04 | 8,580 | — | $0 | 17,160 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | M Exercise | 2020-12-02 | 2020-12-04 | 8,580 | — | $0 | 8,580 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | F Tax w/h | 2020-12-02 | 2020-12-04 | 3,376 | $78.55 | $265.2K | 5,204 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-11-16 | 2020-11-17 | 7,603 | — | $0 | 27,205 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-11-16 | 2020-11-17 | 7,603 | $86.57 | $658.2K | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-11-16 | 2020-11-17 | 7,603 | $66.57 | $506.1K | 13,220 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-11-13 | 2020-11-17 | 13,282 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-11-13 | 2020-11-17 | 13,282 | $83.82 | $1.11M | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-11-13 | 2020-11-17 | 13,282 | $68.50 | $909.8K | 18,899 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-11-10 | 2020-11-12 | 6,000 | — | $0 | 34,808 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-11-10 | 2020-11-12 | 6,000 | $66.57 | $399.4K | 11,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-11-10 | 2020-11-12 | 6,000 | $81.57 | $489.4K | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-11-05 | 2020-11-06 | 3,589 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-11-05 | 2020-11-06 | 3,589 | $64.87 | $232.8K | 9,206 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-11-05 | 2020-11-06 | 3,589 | $79.87 | $286.7K | 5,617 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-11-04 | 2020-11-06 | 1,298 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-11-04 | 2020-11-06 | 1,183 | — | $0 | 2,365 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-11-04 | 2020-11-06 | 3,434 | — | $0 | 3,589 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-11-04 | 2020-11-06 | 1,298 | $68.50 | $88.9K | 24,313 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-11-04 | 2020-11-06 | 1,183 | $66.57 | $78.8K | 25,496 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-11-04 | 2020-11-06 | 2,481 | $80.00 | $198.5K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-11-04 | 2020-11-06 | 139 | $80.00 | $11.1K | 22,876 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-11-04 | 2020-11-06 | 3,434 | $64.87 | $222.8K | 9,051 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-11-04 | 2020-11-06 | 3,434 | $79.89 | $274.3K | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2020-10-16 | 2020-10-20 | 183 | — | $0 | 7,023 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2020-10-16 | 2020-10-20 | 183 | $79.87 | $14.6K | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2020-10-16 | 2020-10-20 | 183 | $64.87 | $11.9K | 5,800 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-10-12 | 2020-10-14 | 8,890 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-12 | 2020-10-14 | 8,890 | $78.53 | $698.1K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-12 | 2020-10-14 | 8,890 | $60.39 | $536.9K | 31,905 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-10-07 | 2020-10-07 | 1,500 | — | $0 | 8,890 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-07 | 2020-10-07 | 1,500 | $60.39 | $90.6K | 24,515 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-10-07 | 2020-10-07 | 1,500 | $78.50 | $117.8K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-10-06 | 2020-10-07 | 4,778 | — | $0 | 10,390 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-06 | 2020-10-07 | 4,778 | $60.39 | $288.5K | 27,793 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-10-06 | 2020-10-07 | 4,778 | $78.50 | $375.1K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-10-05 | 2020-10-07 | 10,437 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-10-05 | 2020-10-07 | 4,200 | — | $0 | 15,168 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-10-05 | 2020-10-07 | 14,637 | $78.51 | $1.15M | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-05 | 2020-10-07 | 4,200 | $60.39 | $253.6K | 37,652 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-10-05 | 2020-10-07 | 10,437 | $63.95 | $667.4K | 33,452 | SEC↗ |
| Bourdon David | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-05 | 4,362 | — | $0 | 4,362 | SEC↗ |
| Bourdon David | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-05 | 6,598 | — | $0 | 6,598 | SEC↗ |
| Bourdon David | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-09 | 6,575 | — | $0 | 6,575 | SEC↗ |
| Bourdon David | Chief Financial Officer | A Award deriv | 2020-10-01 | 2020-10-09 | 4,362 | — | $0 | 4,362 | SEC↗ |
| Abbott Swati Bargotra | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 6,058 | SEC↗ |
| MACKENZIE GREGORY SCOTT | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 9,805 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 4,909 | SEC↗ |
| SANSONE GUY P | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 7,184 | SEC↗ |
| SHULMAN STEVEN J | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 26,662 | SEC↗ |
| Chen Christopher J | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 2,122 | SEC↗ |
| JOSEPHSON MURAL R | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 2,122 | SEC↗ |
| Feld Peter A | Director | A Award | 2020-06-17 | 2020-06-19 | 2,122 | — | $0 | 4,909 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-06-08 | 2020-06-10 | 1,415 | — | $0 | 10,437 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-06-08 | 2020-06-10 | 1,415 | $78.50 | $111.1K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-06-08 | 2020-06-10 | 1,415 | $63.95 | $90.5K | 24,430 | SEC↗ |
| MURRAY JAMES E | President and COO | P Buy | 2020-05-15 | 2020-05-19 | 4,500 | $67.63 | $304.3K | 4,500 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2020-03-05 | 2020-03-09 | 1,448 | — | $0 | 2,894 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2020-03-05 | 2020-03-09 | 839 | — | $0 | 839 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2020-03-05 | 2020-03-09 | 429 | $60.03 | $25.8K | 23,015 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2020-03-05 | 2020-03-09 | 839 | — | $0 | 22,240 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2020-03-05 | 2020-03-09 | 244 | $60.03 | $14.6K | 21,996 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2020-03-05 | 2020-03-09 | 1,448 | — | $0 | 23,444 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 33,295 | — | $0 | 33,295 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 27,743 | — | $0 | 27,743 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2020-03-04 | 2020-03-06 | 1,474 | — | $0 | 1,474 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2020-03-04 | 2020-03-06 | 5,307 | — | $0 | 5,307 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | A Award deriv | 2020-03-04 | 2020-03-06 | 7,303 | — | $0 | 7,303 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | A Award deriv | 2020-03-04 | 2020-03-06 | 6,085 | — | $0 | 6,085 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | A Award deriv | 2020-03-04 | 2020-03-06 | 18,724 | — | $0 | 18,724 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | A Award deriv | 2020-03-04 | 2020-03-06 | 15,602 | — | $0 | 15,602 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 13,134 | — | $0 | 13,134 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 15,763 | — | $0 | 15,763 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2020-03-04 | 2020-03-06 | 21,850 | — | $0 | 21,850 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2020-03-04 | 2020-03-06 | 18,206 | — | $0 | 18,206 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | M Exercise deriv | 2020-03-03 | 2020-03-05 | 5,675 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise deriv | 2020-03-03 | 2020-03-05 | 4,365 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2020-03-03 | 2020-03-05 | 854 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2020-03-03 | 2020-03-05 | 990 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise deriv | 2020-03-03 | 2020-03-05 | 2,837 | — | $0 | 0 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | F Tax w/h | 2020-03-03 | 2020-03-05 | 1,808 | $56.03 | $101.3K | 35,158 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | M Exercise | 2020-03-03 | 2020-03-05 | 5,675 | — | $0 | 36,966 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | F Tax w/h | 2020-03-03 | 2020-03-05 | 1,541 | $56.03 | $86.3K | 5,617 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise | 2020-03-03 | 2020-03-05 | 4,365 | — | $0 | 7,158 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2020-03-03 | 2020-03-05 | 990 | — | $0 | 21,721 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2020-03-03 | 2020-03-05 | 298 | $56.03 | $16.7K | 20,731 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2020-03-03 | 2020-03-05 | 854 | — | $0 | 21,029 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2020-03-03 | 2020-03-05 | 320 | $56.03 | $17.9K | 21,401 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | F Tax w/h | 2020-03-03 | 2020-03-05 | 1,318 | $56.03 | $73.8K | 22,869 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise | 2020-03-03 | 2020-03-05 | 2,837 | — | $0 | 24,187 | SEC↗ |
| Haddock David | General Counsel & Secretary | A Award deriv | 2020-03-02 | 2020-03-04 | 10,605 | — | $0 | 10,605 | SEC↗ |
| Haddock David | General Counsel & Secretary | A Award deriv | 2020-03-02 | 2020-03-04 | 12,710 | — | $0 | 12,710 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-01-02 | 2020-01-03 | 100 | — | $0 | 19,368 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2020-01-02 | 2020-01-03 | 100 | — | $0 | 11,852 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2020-01-02 | 2020-01-06 | 14,006 | — | $0 | 14,006 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2020-01-02 | 2020-01-06 | 25,346 | — | $0 | 25,346 | SEC↗ |
| MURRAY JAMES E | President and COO | A Award deriv | 2020-01-02 | 2020-01-06 | 9,786 | — | $0 | 9,786 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-01-02 | 2020-01-03 | 100 | $63.95 | $6.4K | 20,275 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2020-01-02 | 2020-01-03 | 100 | $60.39 | $6.0K | 20,375 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2020-01-02 | 2020-01-03 | 200 | $78.53 | $15.7K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-30 | 2019-12-31 | 104 | — | $0 | 11,952 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-30 | 2019-12-31 | 104 | $63.95 | $6.7K | 20,279 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2019-12-30 | 2019-12-31 | 104 | $78.50 | $8.2K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-27 | 2019-12-30 | 305 | — | $0 | 12,056 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-27 | 2019-12-30 | 301 | — | $0 | 19,468 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-27 | 2019-12-30 | 305 | $63.95 | $19.5K | 20,781 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-27 | 2019-12-30 | 301 | $60.39 | $18.2K | 20,476 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2019-12-27 | 2019-12-30 | 606 | $78.54 | $47.6K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-26 | 2019-12-27 | 715 | — | $0 | 19,769 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-26 | 2019-12-27 | 742 | — | $0 | 12,361 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-26 | 2019-12-27 | 466 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2019-12-26 | 2019-12-27 | 1,923 | $78.52 | $151.0K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-26 | 2019-12-27 | 715 | $60.39 | $43.2K | 20,890 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-26 | 2019-12-27 | 742 | $63.95 | $47.5K | 21,632 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-26 | 2019-12-27 | 466 | $64.87 | $30.2K | 22,098 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-24 | 2019-12-26 | 1,400 | — | $0 | 13,103 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-24 | 2019-12-26 | 3,304 | — | $0 | 466 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-24 | 2019-12-26 | 1,410 | — | $0 | 20,484 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2019-12-24 | 2019-12-26 | 6,114 | $78.54 | $480.2K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-24 | 2019-12-26 | 1,410 | $60.39 | $85.1K | 21,585 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-24 | 2019-12-26 | 1,400 | $63.95 | $89.5K | 22,985 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-24 | 2019-12-26 | 3,304 | $64.87 | $214.3K | 26,289 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-16 | 2019-12-17 | 1,100 | — | $0 | 14,503 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-16 | 2019-12-17 | 910 | — | $0 | 3,770 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-16 | 2019-12-17 | 2,599 | — | $0 | 1,298 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise deriv | 2019-12-16 | 2019-12-17 | 1,126 | — | $0 | 21,894 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-16 | 2019-12-17 | 2,599 | $68.50 | $178.0K | 25,910 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-16 | 2019-12-17 | 910 | $64.87 | $59.0K | 23,311 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-16 | 2019-12-17 | 1,126 | $60.39 | $68.0K | 21,301 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | S Sale | 2019-12-16 | 2019-12-17 | 5,735 | $78.62 | $450.9K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | X Exercise | 2019-12-16 | 2019-12-17 | 1,100 | $63.95 | $70.3K | 22,401 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2019-12-09 | 2019-12-11 | 16,666 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise deriv | 2019-12-09 | 2019-12-11 | 100 | — | $0 | 7,206 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2019-12-09 | 2019-12-11 | 100 | $64.87 | $6.5K | 19,559 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | S Sale | 2019-12-09 | 2019-12-11 | 16,766 | $78.72 | $1.32M | 2,793 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | X Exercise | 2019-12-09 | 2019-12-11 | 16,666 | $60.55 | $1.01M | 19,459 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | A Award deriv | 2019-12-02 | 2019-12-04 | 25,740 | — | $0 | 25,740 | SEC↗ |
| FASOLA KENNETH J | Chief Executive Officer | A Award deriv | 2019-12-02 | 2019-12-04 | 18,411 | — | $0 | 18,411 | SEC↗ |
| SHULMAN STEVEN J | Director | A Award | 2019-08-26 | 2019-08-28 | 21,753 | — | $0 | 24,540 | SEC↗ |
| FINE PERRY G MD | Director | A Award deriv | 2019-06-21 | 2019-06-24 | 2,251 | $66.66 | $150.1K | 2,251 | SEC↗ |
| Abbott Swati Bargotra | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 3,936 | SEC↗ |
| DIAMENT MICHAEL | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 38,365 | SEC↗ |
| MACKENZIE GREGORY SCOTT | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 7,683 | SEC↗ |
| MCBRIDE WILLIAM J | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 38,365 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 2,787 | SEC↗ |
| SANSONE GUY P | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 5,062 | SEC↗ |
| SHULMAN STEVEN J | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 12,787 | SEC↗ |
| Feld Peter A | Director | A Award | 2019-06-21 | 2019-06-24 | 2,251 | — | $0 | 2,787 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2019-05-01 | 2019-05-03 | 536 | — | $0 | 536 | SEC↗ |
| SANSONE GUY P | Director | A Award | 2019-05-01 | 2019-05-03 | 536 | — | $0 | 2,811 | SEC↗ |
| SHULMAN STEVEN J | Director | A Award | 2019-05-01 | 2019-05-03 | 536 | — | $0 | 10,536 | SEC↗ |
| Feld Peter A | Director | A Award | 2019-05-01 | 2019-05-03 | 536 | — | $0 | 536 | SEC↗ |
| GREGOIRE DANIEL N | General Counsel and Secretar | A Award deriv | 2019-03-05 | 2019-03-06 | 6,203 | — | $0 | 6,203 | SEC↗ |
| GREGOIRE DANIEL N | General Counsel and Secretar | A Award deriv | 2019-03-05 | 2019-03-06 | 23,703 | — | $0 | 23,703 | SEC↗ |
| SMITH BARRY M | Chief Executive Officer | A Award deriv | 2019-03-05 | 2019-03-06 | 114,286 | — | $0 | 114,286 | SEC↗ |
| SMITH BARRY M | Chief Executive Officer | A Award deriv | 2019-03-05 | 2019-03-06 | 29,907 | — | $0 | 29,907 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | A Award deriv | 2019-03-05 | 2019-03-06 | 9,164 | — | $0 | 9,164 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | A Award deriv | 2019-03-05 | 2019-03-06 | 35,020 | — | $0 | 35,020 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | A Award deriv | 2019-03-05 | 2019-03-06 | 40,808 | — | $0 | 40,808 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | A Award deriv | 2019-03-05 | 2019-03-06 | 10,679 | — | $0 | 10,679 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | A Award deriv | 2019-03-05 | 2019-03-06 | 20,281 | — | $0 | 20,281 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | A Award deriv | 2019-03-05 | 2019-03-06 | 5,307 | — | $0 | 5,307 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2019-03-05 | 2019-03-06 | 839 | — | $0 | 1,678 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2019-03-05 | 2019-03-06 | 3,548 | — | $0 | 3,548 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2019-03-05 | 2019-03-06 | 928 | — | $0 | 928 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | A Award deriv | 2019-03-05 | 2019-03-06 | 4,342 | — | $0 | 4,342 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2019-03-05 | 2019-03-06 | 249 | $66.57 | $16.6K | 20,175 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2019-03-05 | 2019-03-06 | 839 | — | $0 | 20,424 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2019-03-03 | 2019-03-05 | 1,097 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2019-03-03 | 2019-03-05 | 990 | — | $0 | 990 | SEC↗ |
| GREGOIRE DANIEL N | General Counsel and Secretar | M Exercise deriv | 2019-03-03 | 2019-03-05 | 2,757 | — | $0 | 0 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise deriv | 2019-03-03 | 2019-03-05 | 3,996 | — | $0 | 0 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise deriv | 2019-03-03 | 2019-03-05 | 2,248 | — | $0 | 0 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | M Exercise deriv | 2019-03-03 | 2019-03-05 | 5,195 | — | $0 | 0 | SEC↗ |
| SMITH BARRY M | Chief Executive Officer | M Exercise deriv | 2019-03-03 | 2019-03-05 | 19,980 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise deriv | 2019-03-03 | 2019-03-05 | 853 | — | $0 | 0 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2019-03-03 | 2019-03-05 | 326 | $68.33 | $22.3K | 18,984 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2019-03-03 | 2019-03-05 | 990 | — | $0 | 18,559 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | F Tax w/h | 2019-03-03 | 2019-03-05 | 346 | $69.42 | $24.0K | 18,213 | SEC↗ |
| WEST JEFFREY N | SVP & Controller | M Exercise | 2019-03-03 | 2019-03-05 | 1,097 | — | $0 | 19,310 | SEC↗ |
| GREGOIRE DANIEL N | General Counsel and Secretar | F Tax w/h | 2019-03-03 | 2019-03-05 | 1,065 | $68.33 | $72.8K | 17,723 | SEC↗ |
| GREGOIRE DANIEL N | General Counsel and Secretar | M Exercise | 2019-03-03 | 2019-03-05 | 2,757 | — | $0 | 18,788 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | F Tax w/h | 2019-03-03 | 2019-03-05 | 2,011 | $68.33 | $137.4K | 2,498 | SEC↗ |
| Kamal Mostafa | CEO, Magellan Rx Management | M Exercise | 2019-03-03 | 2019-03-05 | 3,996 | — | $0 | 4,509 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | M Exercise | 2019-03-03 | 2019-03-05 | 2,248 | — | $0 | 22,393 | SEC↗ |
| Lewis Clapper Caskie | Chief Human Resources Office | F Tax w/h | 2019-03-03 | 2019-03-05 | 1,043 | $68.33 | $71.3K | 21,350 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | F Tax w/h | 2019-03-03 | 2019-03-05 | 1,650 | $68.33 | $112.7K | 31,291 | SEC↗ |
| Rubin Jonathan N | Chief Financial Officer | M Exercise | 2019-03-03 | 2019-03-05 | 5,195 | — | $0 | 32,941 | SEC↗ |
| SMITH BARRY M | Chief Executive Officer | F Tax w/h | 2019-03-03 | 2019-03-05 | 8,399 | $68.33 | $573.9K | 42,120 | SEC↗ |